COGNEX CORP
For the period ended Mar 30, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2025 · Filed May 1, 2025
CGNX$50.34+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ Equity
| Common Stock · AdditionalPaid-in Capital · Retained Earnings · AccumulatedOtherComprehensiveLoss · TotalShareholders’Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Par Value | ||||||
| Balance as of December 31, 2024 | 170,434 | $341 | $1,090,638 | $499,303 | $(72,777) | $1,517,505 |
| Net issuance of common stock under stock plans | 478 | 1 | (2,588) | — | — | (2,587) |
| Repurchase of common stock | (3,047) | (6) | — | (103,407) | — | (103,413) |
| Stock-based compensation expense | — | — | 9,939 | — | — | 9,939 |
| Payment of dividends ($0.080 per common share) | — | — | — | (13,550) | — | (13,550) |
| Net income | — | — | — | 23,603 | — | 23,603 |
| Net unrealized gain (loss) on available-for-sale investments, net of tax of $875 | — | — | — | — | 2,711 | 2,711 |
| Reclassification of net realized (gain) loss on the sale of available-for-sale investments | — | — | — | — | (27) | (27) |
| Foreign currency translation adjustment | — | — | — | — | 11,447 | 11,447 |
| Balance as of March 30, 2025 (unaudited) | 167,865 | $336 | $1,097,989 | $405,949 | $(58,646) | $1,445,628 |
| Common Stock · AdditionalPaid-in Capital · Retained Earnings · AccumulatedOtherComprehensiveLoss · TotalShareholders’Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Par Value | ||||||
| Balance as of December 31, 2023 | 171,599 | $343 | $1,037,202 | $512,543 | $(45,336) | $1,504,752 |
| Net issuance of common stock under stock plans | 294 | — | (2,861) | — | — | (2,861) |
| Repurchase of common stock | (231) | — | — | (9,339) | — | (9,339) |
| Stock-based compensation expense | — | — | 13,302 | — | — | 13,302 |
| Payment of dividends ($0.075 per common share) | — | — | — | (12,888) | — | (12,888) |
| Net income | — | — | — | 12,022 | — | 12,022 |
| Net unrealized gain (loss) on available-for-sale investments, net of tax of $117 | — | — | — | — | 359 | 359 |
| Reclassification of net realized (gain) loss on the sale of available-for-sale investments | — | — | — | — | (2) | (2) |
| Foreign currency translation adjustment | — | — | — | — | (16,156) | (16,156) |
| Balance as of March 31, 2024 (unaudited) | 171,662 | $343 | $1,047,643 | $502,338 | $(61,135) | $1,489,189 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.